Patents
Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
01/2005
01/27/2005WO2004091613A3 Substituted phenyl acetamides and their use as protease inhibitors
01/27/2005WO2004089276A3 Thiazolidinedione compounds with hypoglycemic properties
01/27/2005US20050020684 Modulators of peroxisome proliferator activated receptors
01/27/2005US20050020680 Hydroxyfattysulfonic acid analogs
01/27/2005US20050020651 Butyric acid derivatives
01/27/2005US20050020634 Acat inhibitors; cardiovascular disorders; restenosis; Alzheimer's disease
01/27/2005US20050020584 Benzamide derivatives as antagonists of orexin receptors
01/27/2005US20050020481 Ion channel modulating compounds and uses thereof
01/27/2005US20050020450 Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
01/27/2005US20050019825 Common ligand mimics: pseudothiohydantoins
01/27/2005US20050015898 Hair dyes for keratin fibers
01/27/2005DE10331496A1 Verfahren zum Herstellen von Difluoracetessigsäurealkylestern A process for producing Difluoracetessigsäurealkylestern
01/27/2005CA2533199A1 Reactive polymers and copolymers, method of their preparation and their use
01/26/2005EP1500655A1 New methionine aminopeptidase inhibitor
01/26/2005EP1499609A2 Pesticidal heterocycles
01/26/2005EP1499601A1 New 2-substituted -1,3-thiazole compounds
01/26/2005EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
01/26/2005EP1499578A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
01/26/2005EP1278754B1 Cephalosporin intermediates
01/26/2005EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds
01/26/2005CN1571667A Inhibitors of dipeptidyl peptidase ó¶
01/26/2005CN1186326C Propane-1, 3-dione derivatives
01/25/2005US6846958 Synthesis of benzimidate from benzoic acid
01/25/2005US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
01/25/2005US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
01/25/2005US6846830 Naphtalene derivatives and their pharmaceutical use
01/25/2005US6846825 Antibacterial agents
01/25/2005US6846813 For inhibiting beta-secretase enzyme activity and A beta peptide production, inhibition of beta-secretase enzyme activity halts or reduces production of A beta from APP and reduces or eliminates the formation of beta-amyloid deposits
01/25/2005CA2107153C Method for obtaining and processing seismic data recorded from sensors installed vertically in the underground to follow the movement of fluids in an underground reservoir
01/20/2005US20050014952 Therapy for prostate and breast cancer; benign prostatic hyperplasia, alopecia; eating disorders;
01/20/2005US20050014941 Cyanoalkylamino derivatives as protease inhibitors
01/20/2005US20050014833 Cyclic compound and ppar agonist
01/20/2005US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents
01/20/2005US20050014803 Enzyme inhibitors
01/20/2005US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof
01/20/2005US20050014765 Aryl-heteroaromatic products, compositions comprising them and use
01/20/2005US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules
01/20/2005US20050014745 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors
01/20/2005US20050014703 Cell differentiation, regeneration of epithelium pancreas cells into insulin producing beta-cells; administrering a peptidyl- peptidase activator
01/19/2005EP1498411A1 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
01/19/2005EP1497672A2 Ultrasonic doppler effect speed measurement
01/19/2005EP1497271A1 Indane acetic acid derivatives and their use as pharmaceutical agents
01/19/2005EP1497270A1 Amide compounds and methods of using the same
01/19/2005EP1497245A1 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS
01/19/2005EP1496877A2 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
01/19/2005EP1496838A2 Substituted amides
01/19/2005EP1287018B1 Thrombin inhibitors
01/19/2005CN1568325A Cross-linked glycopeptide-cephalosporin antibiotics
01/19/2005CN1568316A Activator for peroxisome proliferator-responsive receptor delta
01/19/2005CN1568310A Heterocyclic inhibitors of glycogen synthase kinase GSK-3
01/19/2005CN1568185A Compounds effecting glucokinase
01/19/2005CN1566104A Agents for combating plant pests
01/19/2005CN1566103A Moguisteine crystallographic form
01/19/2005CN1566096A Prostaglandin agonists and their use to treat bonedisorders
01/19/2005CN1185223C Novel Compounds and methods for synthesis and therapy
01/19/2005CN1185220C Para-amino substituted phenylamide glucokinase activators
01/19/2005CN1185219C Trans olefinic glucokinase activators
01/19/2005CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use
01/19/2005CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines
01/13/2005WO2005003107A1 Nematicidal thiazoline-containing fluorobutenes
01/13/2005WO2005003098A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents
01/13/2005WO2005003077A1 Method for producing difluoro-acetyl-acetic acid alkylesters
01/13/2005WO2005002622A1 Pain threshold fall inhibitor
01/13/2005WO2004099134A3 Glutaminyl based dp iv-inhibitors
01/13/2005US20050009900 3-Substituted with a heterocyclic group, e.g., 2-Chloro-5-[1-(2,3-dihydroxy-propyl)-5-methyl-1H-pyrazol-3-yl]-N-(1-hydroxy-cycloheptylmethyl)-benzamide; treatment of IL-1 mediated disorders, including osteo- and rheumatoid arthritis, allergies, asthma, COPD, cancer, and reperfusion or ischemia in stroke
01/13/2005US20050009892 Phenyloxazole derivatives lower blood triglyceride, glucose, insulin; hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity; 2-methyl-2-[6-(5-methyl-2-phenyloxazol-4-yl)-(E)-4-hexenyloxy]propionic acid
01/13/2005US20050009890 E.g., 1) (2R)-N-(4-phenoxybenzyl)-3-cyclohexylmethylthio-2-((4R)-3-methoxymethylcarbonylthiazolidin-4-ylcarbonylamino)propanamide; treatment of cerebral infarct, transient ischemic attack, encephalomyelopathy, spinal angiopathy, hypertension with stress, neurosis, epilepsy, asthma, pollakiuria, and pain
01/13/2005US20050009883 Fipronil and chloropyridine or chlorothiazole derivatives as antagonists of nicotinic acetylcholine receptors; protection of industrial materials and plants.
01/13/2005US20050009839 Novel azoles having an insecticidal action
01/13/2005US20050009816 Potassium channel modulators
01/13/2005US20050009785 Heterocyclic compounds
01/13/2005CA2531060A1 Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents
01/13/2005CA2529727A1 Nematicidal thiazoline-containing fluorobutenes
01/12/2005EP1496053A1 Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative
01/12/2005EP1496052A1 Novel aminobenzamide derivative
01/12/2005EP1495015A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
01/12/2005EP1495007A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses
01/12/2005EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors
01/12/2005EP1494997A1 Substituted aryl amides
01/12/2005EP1494641A2 Aminophenylbenzothiazole compounds
01/12/2005EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
01/12/2005CN1564816A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
01/12/2005CN1564813A Intermediate for biotin and process for producing the same
01/12/2005CN1564811A Acylsulfonamides as inhibitors of steroid sulfatase
01/12/2005CN1562987A Metal chelate of short wavelength, and preparation method
01/12/2005CN1562984A Compound of hydrosulfuryl-substitution azacycle
01/12/2005CN1184215C Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
01/12/2005CN1184214C Alpha-acyl and alpha-heteroatom-bustituted benzene acetamide glucokinase activators
01/11/2005US6841682 Prevent binding of adrenergenic receptors
01/11/2005US6841569 Treatment of central nervous system disorders; anticonvulsants, antiepileptics, neuroprotective agents and muscle relaxants
01/11/2005US6841559 Prevention or inhibition of normal pilus assembly in Gram-negative bacterium impacts the pathogenicity of the bacterium
01/06/2005WO2005000852A2 Product containing at least one phosphatase cdc25 inhibitor combined with at least one other anticancer agent
01/06/2005WO2005000843A2 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof
01/06/2005WO2005000842A1 Benzothiazole derivatives as adenosine receptor ligands
01/06/2005WO2005000826A1 Urea derivatives of piperazines and piperidines as fatty acid oxidation inhibitors
01/06/2005WO2005000825A1 Thiazolimine compound and oxazolimine compound
01/06/2005WO2005000824A1 Lazolidine derivatives as herbicidal agents
01/06/2005WO2005000798A1 Heterocyclic methyl sulfone derivative
01/06/2005WO2005000781A1 Biaryloxymethylarene-carboxylic acids
01/06/2005WO2005000406A2 Treatment of amyloid- and epileptogenesis-associated diseases